Brand name · Chemotherapy / VEGF Biologic
Avastin (Bevacizumab) J-Code / HCPCS Code
In short
Avastin is billed under HCPCS J9035 — Injection, bevacizumab, 10 mg. One billing unit is 10 mg.
Bevacizumab biosimilars have their own HCPCS codes.
Reference
- Code
- J9035 — Injection, bevacizumab, 10 mgMed-Code curated
- Billing unit
- 10 mg
- Same code in the directory
- Bevacizumab
- Pharmacologic class
- Vascular Endothelial Growth Factor InhibitorFrom the FDA listings below
- Labelers
- Genentech, Inc.
- J-code category
- Chemotherapy / VEGF Biologic
FDA-listed products
Finished products whose name and route match this directory entry.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Avastinbevacizumab | Bevacizumab 100 mg/4mL | Injection, SolutionIntravenous | Genentech, Inc. | 50242-060 |
| Avastinbevacizumab | Bevacizumab 400 mg/16mL | Injection, SolutionIntravenous | Genentech, Inc. | 50242-061 |
NDCs billed under J9035
CMS’s ASP NDC–HCPCS crosswalk (effective October 1, 2026 through December 31, 2026) assigns 2 NDCs to J9035 for Avastin. Billing units per package are CMS’s figures for this code’s unit.
| Drug | NDC (11-digit) | Labeler | Package | Billing units per package |
|---|---|---|---|---|
| Avastin | 50242-0060-01 | Genentech, Inc. | 4 | 10 |
| Avastin | 50242-0061-01 | Genentech, Inc. | 16 | 40 |